Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name BMS-986416
Trade Name
Synonyms AVID200|AVID 200|AVID-200|BMS986416|BMS 986416
Drug Descriptions

BMS-986416 (AVID200) is a TGF-beta receptor-based TGF-beta trap, which neutralizes TGF-beta1 and TGF-beta3 without interfering with TGF-beta2, resulting in decreased downstream signaling and potentially leading to increased recruitment and activation of anti-tumor T cells (Cancer Res July 1 2017 (77) (13 Supplement) 4688).

CAS Registry Number 2269485-28-9
NCIT ID C159817


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
BMS-986416 BMS-986416 0 3
BMS-986416 + Nivolumab BMS-986416 Nivolumab 0 1

Additional content available in CKB BOOST